Phreesia, Inc. (NYSE:PHR) Receives $29.76 Average PT from Analysts

Shares of Phreesia, Inc. (NYSE:PHR) have been given an average rating of “Moderate Buy” by the nineteen ratings firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seventeen have assigned a buy recommendation to the company. The average 1-year price target among brokerages that have covered the stock in the last year is $29.7647.

Several equities research analysts have weighed in on PHR shares. BMO Capital Markets started coverage on Phreesia in a research report on Thursday, November 13th. They set an “outperform” rating and a $32.00 price target on the stock. Truist Financial set a $24.00 target price on Phreesia in a report on Thursday, January 8th. DA Davidson reduced their price target on Phreesia from $35.00 to $30.00 and set a “buy” rating for the company in a research report on Friday, January 23rd. Zacks Research lowered Phreesia from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, January 6th. Finally, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Phreesia in a research note on Wednesday.

Insider Activity at Phreesia

In related news, insider David Linetsky sold 6,106 shares of the company’s stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $103,863.06. Following the completion of the transaction, the insider owned 231,723 shares in the company, valued at $3,941,608.23. This represents a 2.57% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Allison C. Hoffman sold 6,585 shares of the stock in a transaction dated Thursday, January 8th. The shares were sold at an average price of $17.01, for a total transaction of $112,010.85. Following the completion of the sale, the general counsel owned 174,762 shares of the company’s stock, valued at $2,972,701.62. This trade represents a 3.63% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 60,766 shares of company stock valued at $1,013,817 in the last three months. Company insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Phreesia

A number of hedge funds have recently made changes to their positions in PHR. Raymond James Financial Inc. boosted its position in shares of Phreesia by 2.7% during the second quarter. Raymond James Financial Inc. now owns 14,049 shares of the company’s stock worth $400,000 after purchasing an additional 375 shares in the last quarter. PNC Financial Services Group Inc. raised its stake in Phreesia by 2.8% during the 2nd quarter. PNC Financial Services Group Inc. now owns 19,983 shares of the company’s stock worth $569,000 after buying an additional 540 shares during the period. Diversified Trust Co lifted its holdings in Phreesia by 1.7% during the third quarter. Diversified Trust Co now owns 45,822 shares of the company’s stock worth $1,078,000 after acquiring an additional 780 shares in the last quarter. Oppenheimer Asset Management Inc. grew its stake in Phreesia by 9.9% in the second quarter. Oppenheimer Asset Management Inc. now owns 8,803 shares of the company’s stock valued at $251,000 after acquiring an additional 792 shares during the period. Finally, Alliancebernstein L.P. grew its stake in Phreesia by 1.3% in the third quarter. Alliancebernstein L.P. now owns 62,712 shares of the company’s stock valued at $1,475,000 after acquiring an additional 812 shares during the period. Hedge funds and other institutional investors own 92.10% of the company’s stock.

Phreesia Stock Performance

Shares of PHR stock opened at $13.41 on Monday. Phreesia has a 12-month low of $13.40 and a 12-month high of $32.76. The business’s fifty day simple moving average is $17.18 and its 200-day simple moving average is $22.37. The company has a current ratio of 2.44, a quick ratio of 2.44 and a debt-to-equity ratio of 0.01. The company has a market cap of $808.49 million, a PE ratio of -134.09 and a beta of 0.65.

Phreesia (NYSE:PHR) last issued its quarterly earnings results on Monday, December 8th. The company reported $0.10 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.11. The business had revenue of $120.33 million for the quarter, compared to analyst estimates of $119.98 million. Phreesia had a negative return on equity of 1.31% and a negative net margin of 1.16%.The company’s revenue was up 12.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned ($0.25) earnings per share. Analysts expect that Phreesia will post -1.1 earnings per share for the current fiscal year.

About Phreesia

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.